Literature DB >> 12016423

Molecular diagnosis of viral hepatitis.

Jean-Michel Pawlotsky1.   

Abstract

Molecular biology-based assays are invaluable tools for the management of chronic viral hepatitis. They can be used to test blood donations, diagnose active infection, help to establish the prognosis, guide treatment decisions, and assess the virological response to therapy. This article reviews current molecular biology-based techniques and assays, and their practical use in the management of hepatitis B and C virus infection.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12016423     DOI： 10.1053/gast.2002.33428

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


  53 in total

1.  Review.

Authors:  Usman Khokhar; Debra Stevens; Linda K Shipton; Daryl T-Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

Review 2.  Diagnosis of hepatitis via nanomaterial-based electrochemical, optical or piezoelectrical biosensors: a review on recent advancements.

Authors:  Soodabeh Hassanpour; Behzad Baradaran; Miguel de la Guardia; Amir Baghbanzadeh; Jafar Mosafer; Maryam Hejazi; Ahad Mokhtarzadeh; Mohammad Hasanzadeh
Journal:  Mikrochim Acta       Date:  2018-12-01       Impact factor: 5.833

3.  Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.

Authors:  Karine Gourlain; Alexandre Soulier; Bertrand Pellegrin; Magali Bouvier-Alias; Christophe Hézode; Françoise Darthuy; Jocelyne Rémiré; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Comparison of HCV core antigen and anti-HCV with HCV RNA results.

Authors:  Cicioğlu Arıdoğan Buket; Aynali Ayşe; Kaya Selçuk; Önal Süleyman; Sesli Çetin Emel
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

5.  Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction.

Authors:  D Olioso; M Boaretti; M Ligozzi; G Lo Cascio; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

6.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human immunodeficiency virus coinfection by using the Versant HCV RNA 3.0 (branched DNA-based) DNA assay.

Authors:  Rosamaria Tedeschi; Eliana Pivetta; Stefania Zanussi; Ettore Bidoli; Mirna Ros; Giampiero di Gennaro; Guglielmo Nasti; Paolo De Paoli
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA.

Authors:  David A Hendricks; Michel Friesenhahn; Lorine Tanimoto; Bernd Goergen; Deborah Dodge; Lorraine Comanor
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Syria Laperche; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

10.  The laboratory diagnosis of hepatitis B virus.

Authors:  Mel Krajden; Gail McNabb; Martin Petric
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.